| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,
* Trudeau Institute, Saranac Lake, NY 12983; Departments of
Internal Medicine and
Microbiology, Immunology, and Molecular Genetics, University of Kentucky and
Veterans Administration Medical Center, Lexington, KY 40536
Both CD4+ T cells and B cells are critical for defense against Pneumocystis carinii infection; however, the mechanism by which B cells mediate protection is unknown. We show that P. carinii-specific IgM is not sufficient to mediate clearance of P. carinii from the lungs since CD40-deficient mice produced normal levels of specific IgM, but were unable to clear the organisms. Using chimeric mice in which the B cells were deficient in CD40 (CD40KO chimeras) we found that clearance of P. carinii infection is delayed compared with wild-type controls. These CD40KO chimeric mice produced normal levels of P. carinii-specific IgM, but did not produce class-switched IgG or IgA. Similarly, clearance of P. carinii was delayed in mice deficient in Fc
RI and III (FcRKO), indicating that P. carinii-specific IgG partially mediates opsonization and clearance of P. carinii. Opsonization of organisms by complement did not compensate for the lack of specific IgG or FcR, since C3-deficient and C3-depleted FcRKO mice were still able to clear P. carinii. Finally, µMT and CD40KO chimeric mice had reduced numbers of activated CD4+ T cells in the lungs and lymph nodes compared with wild-type mice, suggesting that B cells are important for activation of T cells in response to P. carinii. Together these data indicate that P. carinii-specific IgG plays an important, but not critical, role in defense against P. carinii. Moreover, these data suggest that B cells also mediate host defense against P. carinii by facilitating CD4+ T cell activation or expansion.
This article has been cited by other articles:
|
|
 |
|
  M. P. Nelson, A. E. Metz, S. Li, C. A. Lowell, and C. Steele The Absence of Hck, Fgr, and Lyn Tyrosine Kinases Augments Lung Innate Immune Responses to Pneumocystis murina Infect. Immun., May 1, 2009; 77(5): 1790 - 1797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Beck and M. T. Cushion Pneumocystis Workshop: 10th Anniversary Summary Eukaryot. Cell, April 1, 2009; 8(4): 446 - 460. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Hernandez-Novoa, L. Bishop, C. Logun, P. J. Munson, E. Elnekave, Z. G. Rangel, J. Barb, R. L. Danner, and J. A. Kovacs Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice J. Leukoc. Biol., August 1, 2008; 84(2): 420 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hollifield, E. B. Ghanem, W. J. S. de Villiers, and B. A. Garvy Scavenger Receptor A Dampens Induction of Inflammation in Response to the Fungal Pathogen Pneumocystis carinii Infect. Immun., August 1, 2007; 75(8): 3999 - 4005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Rapaka, E. S. Goetzman, M. Zheng, J. Vockley, L. McKinley, J. K. Kolls, and C. Steele Enhanced Defense against Pneumocystis carinii Mediated by a Novel Dectin-1 Receptor Fc Fusion Protein J. Immunol., March 15, 2007; 178(6): 3702 - 3712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Huang, A. Morris, A. H. Limper, J. M. Beck, and on behalf of the ATS Pneumocystis Workshop Partici An Official ATS Workshop Summary: Recent Advances and Future Directions in Pneumocystis Pneumonia (PCP) Proceedings of the ATS, November 1, 2006; 3(8): 655 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Lasbury, P. J. Durant, C. A. Ray, D. Tschang, R. Schwendener, and C.-H. Lee Suppression of Alveolar Macrophage Apoptosis Prolongs Survival of Rats and Mice with Pneumocystis Pneumonia. J. Immunol., June 1, 2006; 176(11): 6443 - 6453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Lund, M. Hollifield, K. Schuer, J. L. Lines, T. D. Randall, and B. A. Garvy B Cells Are Required for Generation of Protective Effector and Memory CD4 Cells in Response to Pneumocystis Lung Infection J. Immunol., May 15, 2006; 176(10): 6147 - 6154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Feola and B. A. Garvy Combination Exposure to Zidovudine plus Sulfamethoxazole-Trimethoprim Diminishes B-Lymphocyte Immune Responses to Pneumocystis murina Infection in Healthy Mice Clin. Vaccine Immunol., February 1, 2006; 13(2): 193 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Vowinkel, K. C. Wood, K. Y. Stokes, J. Russell, C. F. Krieglstein, and D. N. Granger Differential expression and regulation of murine CD40 in regional vascular beds Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H631 - H639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wells, C. G. Haidaris, T. W. Wright, and F. Gigliotti Complement and Fc Function Are Required for Optimal Antibody Prophylaxis against Pneumocystis carinii Pneumonia Infect. Immun., January 1, 2006; 74(1): 390 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Meissner, F. E. Lund, S. Han, and A. Harmsen CD8 T Cell-Mediated Lung Damage in Response to the Extracellular Pathogen Pneumocystis Is Dependent on MHC Class I Expression by Radiation-Resistant Lung Cells J. Immunol., December 15, 2005; 175(12): 8271 - 8279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Yager, C. Bitsaktsis, B. Nandi, J. W. McBride, and G. Winslow Essential Role for Humoral Immunity during Ehrlichia Infection in Immunocompetent Mice Infect. Immun., December 1, 2005; 73(12): 8009 - 8016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Empey, M. Hollifield, K. Schuer, F. Gigliotti, and B. A. Garvy Passive Immunization of Neonatal Mice against Pneumocystis carinii f. sp. muris Enhances Control of Infection without Stimulating Inflammation Infect. Immun., November 1, 2004; 72(11): 6211 - 6220. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
